中文名称：匹格列酮
  • 5-[[4-[2-(5-乙基吡啶-2-基)乙氧基]苯基]甲基]-1,3-噻唑烷-2,4-二酮; 5-[4-[2-(5-乙基-2-吡啶)乙氧基]苄基]-2,4-噻唑烷二酮; 吡格列酮
  • Pioglitazone
  • 5-[4-[2-(5-ETHYL-2-PYRIDINYL)ETHOXY]PHENYL]METHYL-2,4-THIAZOLIDINEDIONE; 5-(4-[2-(5-ETHYL-PYRIDIN-2-YL)-ETHOXY]-BENZYL)-THIAZOLIDINE-2,4-DIONE; 5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione; Pioglitazone free base; Pioglitazone and its intermeidates; PIOGLITAZONE HCL(5-[[4-[2-(5-ETHYLPYRIDIN-2-YL)ETHOXY]PHENYL]METHYL]THIAZOLIDINE-2,4-DIONE, HCL); PINEPOLLEN KY-18; Pioglitazone base; 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione; 5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione hydrochloride (1:1)
  • 111025-46-8;105355-27-9
  • C19H21ClN2O3S
  • 392.8996
  • InChI=1/C19H20N2O3S.ClH/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17;/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23);1H
  • 匹格列酮 111025-46-8;105355-27-9
  • 575.4°C at 760 mmHg
  • 301.8°C
  • 3.03E-13mmHg at 25°C
  • 用于治疗(Ⅱ)型糖尿病